(secondQuint)Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease.

 Participants received 12 infusions of 0.

1 g/kg, 0.

25 g/kg, or 0.

4 g/kg body weight octagam 10% at 2-week intervals (3 days) or 6 infusions of 0.

2 g/kg, 0.

5 g/kg, or 0.

8 g/kg body weight octagam 10% at 4-week intervals (5 days).

 The effect of the infusions on the reduction of A peptide in CSF and the increase of A peptide in blood plasma was evaluated.

.

 Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease@highlight

This study evaluated the effect of 6 or 12 infusions of different doses of octagam (intravenous immunoglobulin [IVIG]) 10% on the reduction of amyloid beta peptide (A) in cerebral spinal fluid (CSF) and on the increase of A in blood plasma in patients with mild to moderate Alzheimer's disease.

